Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer

Urology

Volumn 61, Issue 5, 2003, Pages 977-981

  Kravchick, Sergey ^a   Cytron, Shmuel ^b   Peled, Ronit ^b   Altshuler, Alexander ^b   Ben Dor, David ^b  

^a BARZILAI MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; CANCER DIAGNOSIS; CLINICAL TRIAL; COLOR; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GRAY SCALE ECHOGRAPHY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; RATING SCALE; TECHNIQUE; TUMOR BIOPSY; TUMOR VASCULARIZATION;

EID: 0037963943     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02520-7     Document Type: Article

References (21)

1. Catalona W.J., Richie J.P., Ahmann F.R., et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer results of a multicenter clinical trial of 6,630 men . J Urol. 151:1994;1283-1290.
2. Cooper W.H., Mosley B.R., Rutherford C.T. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 143:1990;1146-1154.
3. Hinman F. Screening for prostatic cancer. J Urol. 145:1991;126-130.
4. Shinohara K., Wheeler T.M., Scardino P.J. The appearance of prostate cancer on transrectal ultrasonography correlation of imaging and pathological examinations . J Urol. 142:1989;76-82.
5. Epstein J.I., Walsh P.S., Saauvageot J., et al. Use of repeat sextant and transitional zone biopsies for assessing extent of prostate cancer. J Urol. 158:1997;1886-1890.
6. Norberg M., Egevad L., Holmberg L., et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 50:1997;562-566.
7. Rifkin M.D., Sudakoff G.S., Archibald A.A. Prostate technique, results and potential application of color Doppler US scanning . Radiology. 186:1993;509-513.
8. Plawker M.W., Fleisher J.M., Vapner E.M., et al. Current trends in prostate cancer diagnosis and staging among United States urologists. J Urol. 158:1997;1853-1858.
9. Rifkin M.D., Dahnert W., Kurtz A.B. State of the art endorectal sonography of the prostate gland . AJR Am J Roentgenol. 154:1990;691-700.
10. Lavoipierre A.M., Snow R.M., Frydenberg M. Prostatic cancer role of color Doppler imaging in transrectal sonography . AJR Am J Roentgenol. 171:1998;205-210.
11. Louvar E., Littrup P.J., Goldstein A., et al. Correlation of color flow in the prostate with tissue microvascularity. Cancer. 83:1998;135-140.
12. Ismail M., Petersen R.O., Alexander A.A., et al. Color Doppler imaging in predicting the biologic behavior of prostate cancer correlation with disease-free survival . Urology. 50:1997;906-912.
13. Halpern E.J., Strup S.E. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol. 174:2000;623-627.
14. Cornud F., Belin X., Piron D., et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level impact on Gleason score for non-palpable lesions . Urology. 49:1997;709-715.
15. Newman J.S., Bree R.L., Rubin J.M. Prostatic cancer diagnosis with color Doppler sonography with histologic correlation of each biopsy site . Radiology. 195:1995;86-90.
16. Wingo P.A., Tong T., Bolden S. Cancer statistics. CA Cancer J Clin. 45:1995;8-31.
17. Naughton C.K., Smith D.S., Humphrey P.A., et al. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores a retrospective study . Urology. 52:1998;806-813.
18. Eskew L.A., Bare R.L., McCullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 157:1997;199-202.
19. Presti J.C., Chang J.J., Bhargava V., et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies results of a prospective clinical trial . J Urol. 163:2000;163-167.
20. Babain R.J., Toi A., Kamoi K., et al. A comparative analysis of sextant and extended 11-core multisite directed biopsy strategy. J Urol. 163:2000;152-157.
21. Naughton C.K., Ornstein D.K., Smith D.S., et al. Pain and morbidity of transrectal ultrasound guided prostate biopsy a prospective randomized trial of 6 versus 12 cores . J Urol. 163:2000;168-171.